Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS)

被引:3
作者
Rabner, Jonathan [1 ,11 ]
Olino, Thomas M. [1 ]
Albano, Anne Marie [2 ]
Keeton, Courtney P. [3 ]
Sakolsky, Dara [4 ,5 ]
Birmaher, Boris [4 ,5 ]
Piacentini, John [6 ]
Peris, Tara S. [6 ]
Compton, Scott N. [7 ]
Gosch, Elizabeth [8 ]
Ginsburg, Golda S. [9 ]
Pinney, Elizabeth L. [10 ]
Kendall, Philip C. [1 ]
机构
[1] Temple Univ, Dept Psychol & Neuorsci, Philadelphia, PA 19122 USA
[2] Columbia Univ, New York State Psychiat Inst, Dept Psychiat, Med Ctr, New York, NY USA
[3] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD USA
[4] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[5] Univ Pittsburgh, Med Ctr, Western Psychiat Inst & Clin, Pittsburgh, PA USA
[6] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA
[7] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC USA
[8] Philadelphia Coll Osteopath Med, Dept Psychol, Philadelphia, PA USA
[9] Univ Connecticut, Hlth Ctr, Dept Psychiat, Farmington, CT USA
[10] Binghamton Univ, Dept Psychol, Binghamton, NY USA
[11] Temple Univ, Dept Psychol, 1701 North 13th St, Philadelphia, PA 19122 USA
关键词
Anxiety disorders; substance use; youth; cognitive behavioral therapy; secondary prevention; MENTAL-DISORDERS; FOLLOW-UP; DRUG-USE; CHILDREN; ADOLESCENTS; COMORBIDITY; ALCOHOL; GENDER; SCALE; MOOD;
D O I
10.1111/jcpp.13926
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
BackgroundSubstance use problems and anxiety disorders are both highly prevalent and frequently cooccur in youth. The present study examined the benefits of successful anxiety treatment at 3-12 years after treatment completion on substance use outcomes (i.e. diagnoses and lifetime expected use).MethodsThe sample was from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS), a naturalistic follow-up study to the Child/Adolescent Anxiety Multimodal Study (CAMS) which randomized youth to cognitive behavioral therapy (CBT; Coping cat), medication (sertraline), their combination, or pill placebo. The first CAMELS visit occurred an average of 6.5 years following CAMS randomization. Participants were 319 youth (65.4% of the CAMS sample), aged 7-17 years at CAMS baseline assessment with a mean age of 17.6 years (range: 11-26 years) at the time of the first CAMELS follow-up. Substance use outcomes included diagnoses as well as lifetime substance use (i.e. alcohol and tobacco use).ResultsEleven of 319 (3.4%) CAMELS participants were diagnosed with a substance use disorder at the initial follow-up visit. When compared to the population lifetime rate of 11.4%, the rate of diagnoses in the posttreated sample was significantly lower. Additionally, rates of lifetime alcohol use were lower than population rates at the initial and final follow-up visits. Rates of lifetime tobacco use were similarly lower than lifetime population rates at the initial visit (driven by significantly lower rates in the CBT treatment condition), but higher by the final visit. Furthermore, treatment remission (but not treatment response) was associated with a lower rate of substance use diagnoses at the initial follow-up visit, although rates of lifetime alcohol and tobacco use did not differ by treatment outcome.ConclusionsAnxiety treatments confer a beneficial impact on problematic substance use (i.e. diagnoses) as well as on expected substance use (i.e. alcohol and tobacco use) for on average, a period of 6.5 years.
引用
收藏
页码:910 / 920
页数:11
相关论文
共 47 条
[1]  
Albano A., 2006, CLIN GUIDE ANXIETY D
[2]  
Albano A.M., 1996, Anxiety disorders interview schedule for DSM-IV: Child version
[3]  
Angold A, 1995, INT J METHOD PSYCH, V5, P237
[4]   Fitting Linear Mixed-Effects Models Using lme4 [J].
Bates, Douglas ;
Maechler, Martin ;
Bolker, Benjamin M. ;
Walker, Steven C. .
JOURNAL OF STATISTICAL SOFTWARE, 2015, 67 (01) :1-48
[5]   Anxiety and Related Outcomes in Young Adults 7 to 19 Years After Receiving Treatment for Child Anxiety [J].
Benjamin, Courtney L. ;
Harrison, Julie P. ;
Settipani, Cara A. ;
Brodman, Douglas M. ;
Kendall, Philip C. .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2013, 81 (05) :865-876
[6]   Developmental Trajectories of Substance Use From Early Adolescence to Young Adulthood: Gender and Racial/Ethnic Differences [J].
Chen, Pan ;
Jacobson, Kristen C. .
JOURNAL OF ADOLESCENT HEALTH, 2012, 50 (02) :154-163
[7]   PREFERENCES FOR ETHANOL AND DIAZEPAM IN ANXIOUS INDIVIDUALS - AN EVALUATION OF THE SELF-MEDICATION HYPOTHESIS [J].
CHUTUAPE, MAD ;
DEWIT, H .
PSYCHOPHARMACOLOGY, 1995, 121 (01) :91-103
[9]   Association of Lifetime Mental Disorders and Subsequent Alcohol and Illicit Drug Use: Results From the National Comorbidity Survey-Adolescent Supplement [J].
Conway, Kevin P. ;
Swendsen, Joel ;
Husky, Mathilde M. ;
He, Jian-Ping ;
Merikangas, Kathleen R. .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (04) :280-288
[10]   Gender Effects on Drug Use, Abuse, and Dependence: A Special Analysis of Results From the National Survey on Drug Use and Health [J].
Cotto, Jessica H. ;
Davis, Elisabeth ;
Dowling, Gayathri J. ;
Elcano, Jennifer C. ;
Staton, Anna B. ;
Weiss, Susan R. B. .
GENDER MEDICINE, 2010, 7 (05) :402-413